Related Experiment Videos

[Liver diseases in children with alpha 1-antitrypsin deficiency in infancy]

M Durpektová1, J Kamarýt, A Pijácková

  • 1Výzkumný ústav zdraví dítĕte, Brno.

Ceskoslovenska Pediatrie
|September 1, 1992
PubMed

Insights

Neonatal screening identified children with alpha-1-antitrypsin deficiency, revealing varied liver disease severity. Most infants showed no clinical signs, but some developed hepatitis or jaundice, highlighting the need for early detection.

Area of Science:

  • Pediatric Hepatology
  • Genetic Liver Diseases
  • Neonatal Screening

Context:

  • Alpha-1-antitrypsin deficiency (AATD) is a genetic disorder.
  • Infant liver disease diagnosis relies on early identification.
  • Neonatal screening aids in detecting genetic conditions.

Purpose:

  • To assess the liver health status of infants diagnosed with alpha-1-antitrypsin deficiency.
  • To determine the prevalence and spectrum of liver disease in this cohort.
  • To compare findings with international data.

Summary:

  • Twenty-one children identified via neonatal screening for AATD were evaluated.
  • One infant presented with severe neonatal hepatitis progressing to cirrhosis.
  • Two infants had jaundice up to two months; six showed elevated liver enzymes without symptoms; twelve were asymptomatic.

Impact:

  • Highlights the variable clinical presentation of AATD-related liver disease in infancy.
  • Emphasizes the utility of neonatal screening for early AATD detection.
  • Provides data for understanding AATD's impact on pediatric liver health.

Related Concept Videos